- Shop Products
- Services & Tools
- Business Resources
- Clinical Resources
- About Us
- Contact Us
Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat patients who have infectious diseases.
Contact our lab specialists to learn how our solution for antibiotic stewardship can help you work towards these goals and make a positive impact in patient therapy.Contact Us
Since the 1940s, these drugs have greatly reduced illness and death from infectious diseases. However, these drugs have been used so widely and for so long that the infectious organisms the antibiotics are designed to kill have adapted to them, making the drugs less effective. Antibiotic-resistant bacteria are responsible for infecting at least 2 million people annually in the United States and at least 23,000 people die due to these infections.1
Antibiotic resistance comes from a confluence of factors:
As the CDC states, a growing body of evidence demonstrates that hospital-based programs dedicated to improving antibiotic use, commonly referred to as “antibiotic stewardship programs (ASP)”, can both optimize the treatment of infections and reduce adverse events associated with antibiotic use.2,3
McKesson is proud to offer a comprehensive solution for antibiotic stewardship. Our goal is to improve patient safety and conserve antibiotics in all communities nationwide by offering solutions that augment the good work hospitals have already implemented. Our experienced team will work closely with stewardship teams to move from current state to a jointly defined ideal state.
Watch our webinar and panel presentation on how the core elements of an antibiotic stewardship program help reduced hospital acquired infections, patient length of stay and improve overall patient satisfaction here.4, 5 (Registration required.)
In 2015, the White House hosted the Forum on Antibiotic Stewardship to bring together more than 100 key human and animal health leaders involved in antibiotic stewardship-the development, promotion, and implementation of activities to promote optimal use of antibiotics nationwide. They put forth a national action plan that included:
Is your facility on pace to meet the call to action?
1 – https://www.cdc.gov/drugresistance/index.html
2 – https://www.cdc.gov/antibiotic-use/healthcare/implementation/core-elements.html#_ENREF_17
3 – https://www.cdc.gov/antibiotic-use/healthcare/implementation/core-elements.html#_ENREF_18
4 – Hecker MT, Fox CJ, Son AH, et al. Effect of a stewardship intervention on adherence to uncomplicated cystitis and pyelonephritis guidelines in an emergency department setting. PLoS One. 2014;9(2):e87899. doi:10.137/journal.pone.0087899.
5 – Johnstone J, Mandell L. Guidelines and quality measures: do they improve outcomes of patients with community-acquired pneumonia? Infect Dis Clin North Am. 2013;27(1):71-86. doi:10.1016/j.idc.2012.11.001.
Statistics in graphic:
$35B to $45B – https://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf
12M – https://qualitysafety.bmj.com/content/early/2014/04/04/bmjqs-2013-002627
1 in 25 – https://www.cdc.gov/hai/surveillance/index.html
Only 49% – https://www.pharmacytoday.org/article/S1042-0991(17)31637-7/pdf
50% – https://www.cdc.gov/antibiotic-use/stewardship-report/pdf/stewardship-report.pdf
18% – https://www.hcup-us.ahrq.gov/reports/statbriefs/sb196-Readmissions-Trends-High-Volume-Conditions.pdf